Track topics on Twitter Track topics that are important to you
OXiGENE, Inc. is an international biopharmaceutical company engaged principally in research into and thedevelopment of products for use in the treatment of cancer. Historically, the Company's activities have been directed primarily towards products designed to complement and enhance the clinical efficacy of radiation and chemotherapy,
which are the most common and traditional forms of non-surgical cancer treatment. Recently, however, the Company has begun to investigate certain of its developmental stage products for applications as direct cancer treatment
agents, anti-inflammatory agents or in the treatment of fungal or other infectious diseases, as well as for DNA repair measurement and stimulation. Currently, OXiGENE has in various stages of clinical development therapeutic
product candidates that derive from three principal technology platforms.
230 Third Avenue
United States of America
This study is intended to determine the safety and maximum tolerated dose of a drug, OXi4503 (combretastatin A1 diphosphate, CA1P, OXiGENE), in patients with relapsed and refractory AML an...
OXiGENE, Inc. is an international biopharmaceutical company engaged principally in research into and thedevelopment of products for use in the treatment of cancer. Historically, the Com...
We have published hundreds of Oxigene news stories on BioPortfolio along with dozens of Oxigene Clinical Trials and PubMed Articles about Oxigene for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxigene Companies in our database. You can also find out about relevant Oxigene Drugs and Medications on this site too.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...